Peptides Studied in Longevity Research: A Canadian Guide
In 2013 a team of biologists put names to nine 'hallmarks of aging' - mitochondrial decline, genomic instability, a shrinking and slower immune system, and six others. That paper reorganized how the field thinks about getting old, and it handed researchers a rough map of where a molecule might push back. Most of the compounds marketed as peptides for longevity land on one of those hallmarks. Not one of them is a proven anti-aging treatment in people. What they share is a defensible mechanism and a stack of preclinical studies that reward a closer look before you believe the sales copy.
Sorting these compounds by what they act on beats listing them alphabetically, because the mechanism tells you what a study was actually testing. Four families cover most of the ground.
| Compound | Mechanism family | Research focus |
|---|---|---|
| MOTS-c | Mitochondrial and metabolic | AMPK activation, insulin sensitivity, exercise-like signalling |
| NAD+ | Mitochondrial and metabolic | Cellular energy, DNA repair, sirtuin fuel |
| Epithalon | Pineal and circadian | Melatonin rhythm, telomerase expression in cell work |
| Pinealon | Pineal and circadian | Neuroprotection, oxidative-stress models |
| Thymalin | Thymic and immune aging | Thymus-derived immune signalling, T-cell balance |
| Thymosin alpha-1 | Thymic and immune aging | Innate and adaptive immune modulation |
| GHK-Cu | Matrix and regenerative | Collagen, wound and tissue-remodelling gene programs |
Mitochondrial and metabolic: MOTS-c and NAD+
Mitochondria lose output as tissue ages, and two of the most-discussed compounds aim straight at that. MOTS-c is a 16-amino-acid peptide encoded inside mitochondrial DNA, in the 12S rRNA region - one of a small class of mitochondrial-derived peptides. In rodent and cell work it switches on AMPK, the enzyme cells use to sense low energy, which nudges glucose uptake and fat oxidation in a direction that resembles the aftermath of exercise. Researchers have called it an exercise mimetic for that reason, though the label oversells how much we actually know.
NAD sits one layer down, as the coenzyme that carries electrons through energy metabolism and feeds the sirtuin enzymes tied to DNA repair. Tissue NAD+ falls measurably with age, and much of the longevity interest is simply about topping it back up. I've written a longer piece on what the NAD+ studies actually say if you want the detail.
Pineal and circadian: epithalon and pinealon
Epithalon is a four-amino-acid peptide, Ala-Glu-Asp-Gly, that Vladimir Khavinson's group in St. Petersburg derived from a pineal extract called epithalamin. The pineal gland runs the melatonin rhythm that organizes sleep and seasonal timing, and that rhythm flattens with age. Epithalon's headline result - increased telomerase activity in cultured human cells - came out of that same lab and has not been widely replicated elsewhere, so treat it as interesting rather than settled. Pinealon, a Glu-Asp-Arg tripeptide from the same research tradition, shows up mostly in neuroprotection and oxidative-stress models in animals.
Thymic and immune aging: thymalin and thymosin alpha-1
The thymus, where T-cells mature, starts shrinking in your twenties and is mostly fat by later life - a process called thymic involution that tracks closely with a weaker immune response. Thymalin is a polypeptide fraction pulled from calf thymus, studied in Russian gerontology literature for its effect on immune balance in older animals and people. Thymosin alpha-1 is a defined 28-amino-acid peptide that signals through toll-like receptors to tune both innate and adaptive immunity. It is an approved medicine in several countries under brand names owned by their makers, which is a different regulatory category from a research peptide and not interchangeable with one.
Matrix and regenerative: GHK-Cu
GHK-Cu is the copper-binding tripeptide Gly-His-Lys. Plasma levels sit around 200 ng/mL in your early twenties and drop to roughly 80 ng/mL by 60, and that decline maps onto slower wound healing and thinner skin. What makes it interesting for aging research is less the collagen story and more the gene-expression one: in cultured cells GHK-Cu shifts a broad set of genes toward a younger, more regenerative pattern. Whether that translates to a living organism is still an open question.
How strong is the evidence for peptides for longevity?
Honest answer: thinner than the marketing implies. Most of what exists is cell-culture and rodent data, plus a handful of small human studies from a few research groups. Does any of it extend lifespan in a person? No one has shown that. The compounds on the growth-hormone side of aging have their own separate literature, which I cover in the growth hormone axis overview. If you're sourcing any of these for lab use, the mechanism matters less than provenance - a clean certificate of analysis and honest purity testing beat a good backstory every time. You can see the full range on our research catalogue. Read the primary studies, not the reposts, and keep the preclinical caveat in view.
Research use only. This article is educational and is not medical, legal, or financial advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.